Skip to content

Insider · CIK 0001734018

Ferdinand Groenewald

officercfo

Files at TCRT (Alaunos Therapeutics, Inc.), STEX (Streamex Corp.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 18, 2025TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Common Stock
+10,775$0.00$010,775Aug 20, 2025
Aug 18, 2025TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+4,000$0.00$04,000Aug 20, 2025
May 29, 2025STEX
Streamex Corp.
AGrant or award
Common Stock
+175,000$0.00$0235,000Jun 2, 2025
Apr 24, 2025STEX
Streamex Corp.
AGrant or award
Common Stock
+35,000$0.00$060,000Apr 29, 2025
Mar 29, 2025TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+3,000$0.00$03,000Apr 1, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Ferdinand Groenewald: insider trades and track record | InsiderTell